This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundStrategies to estimate risk of cancer therapyrelated cardiac dysfunction (CTRCD) before initiating cardiotoxic cancer treatment are needed. Journal of the American Heart Association, Ahead of Print. Quantitative measurements of ECG waveform parameters were performed using MUSE (GE Healthcare).
Anthracyclines are a well-established class of cancer drugs that are used to treat several types of cancer. While they are effective at eradicating cancer, they are known to carry a risk of causing damage to the heart muscle.
BACKGROUND:Risk stratification strategies for cancer therapeuticsrelated cardiac dysfunction (CTRCD) rely on serial monitoring by specialized imaging, limiting their scalability. Circulation: Cardiovascular Quality and Outcomes, Volume 18, Issue 1 , Page e011504, January 1, 2025. positive screen), respectively. fold and 13.5-fold
A study featuring Fujifilm’s OPIE Transducer highlights that the system provides established imaging to aid in septal myectomy procedures compared to TEE and transthoracic echocardiogram (TTE).
It is well understood that cancer therapies including chemotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors, and radiation can increase the risk of cardiovascular disease in patients with cancer. Circulation: Cardiovascular Imaging, Ahead of Print.
This occurs most commonly in cancer (malignant pericardial effusion). Usually it is cancer of other organs spreading to the pericardium (secondary) rather than primary cancer of the pericardium which is very rare (mesothelioma). This may include medications, radiation, and surgery, depending on the type of cancer.
The researchers developed their ‘CXR CVD-Risk’ model using chest X-rays sourced from a cancer screening trial, and then externally validated the AI model against 11,000 patients’ CXRs. Among the patients with unknown ASCVD risks, those who received a 7.5%
A middle-aged patient with lung cancer had presented to clinic complaining of generalized malaise, cough, and chest pain. Symptoms other than chest pain (malaise, cough in a cancer patient) 2. Exclusion criteria were age less than 18, SBP less than 100 mmHg, echocardiogram with EF less than 50%, STEMI, pregnancy, and trauma.
EKG initially negative but repeat shows a few T wave abnormalities… There is a chance this could be non-cardiac pain” At 1518, an echocardiogram showed normal LV size and systolic function with hypokinesis of the mid and distal anterior wall and the mid and distal septum.
Therefore, the ability to detect cardiac amyloidosis early is critical,” noted Jonathan Wall , PhD, director of the Amyloidosis and Cancer Theranostics Program and professor at the University of Tennessee Graduate School of Medicine in Knoxville, Tennessee.
An 84-year-old male with a history of prostate cancer not on chemotherapy presented to the ED with complaints of shortness of breath worse on exertion ongoing for 1 week accompanied by generalized malaise. Circulation, Volume 150, Issue Suppl_1 , Page A4140751-A4140751, November 12, 2024.
Osimertinib is first-line treatment for epidermal growth factor (EGFR)-mutated non-small cell lung cancer (NSCLC) and has been associated with cardiotoxicity. Retrospective analysis of NSCLC patients with 1 echocardiogram post-osimertinib between 2007 and 2022 was performed.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content